Crescent Biopharma, Inc. (CBIO) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 1.04M | 10.84M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10K | 0 | 0 | 0 | 0 | 0 | 75K | 0 | 17.63K | 86.56K | 142 |
| Revenue Growth % | - | - | - | - | - | -100% | - | - | - | - | - | -100% | - | -100% | -100% | 52716.9% | -100% | -89.18% | -91.34% | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 1.04M | 10.84M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | 100% | 100% | - | - | - | - | - | - | - | 100% | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | -100% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 25.77M | 102.34M | 25.89M | 21.03M | 14.22M | 17.19M | 11.23M | 10.36M | 11.12M | 9.6M | 9.81M | 8.93M | 10.94M | 10.62M | 8.77M | 13.43M | 14.66M | 17.44M | 17.42M | 14.4M |
| OpEx % of Revenue | 2480.08% | 943.71% | - | - | - | - | - | - | - | 96008.34% | - | - | - | - | - | 17904.21% | - | 98970.2% | 20128.82% | 10144101.41% |
| Selling, General & Admin | 7.87M | 7.31M | 5.54M | 8.95M | 3.6M | 3.16M | 4.01M | 4.07M | 5.09M | 4.31M | 4.52M | 4.86M | 5.52M | 4.73M | 3.85M | 5.46M | 5.06M | 4.55M | 4.14M | 4.24M |
| SG&A % of Revenue | 756.98% | 67.4% | - | - | - | - | - | - | - | 43120% | - | - | - | - | - | 7273.33% | - | 25806.55% | 4785.12% | 2983802.82% |
| Research & Development | 17.9M | 95.03M | 20.35M | 12.08M | 10.63M | 14.03M | 1.72M | 6.29M | 6.03M | 5.29M | 5.29M | 4.07M | 5.42M | 5.89M | 4.92M | 7.97M | 9.6M | 12.9M | 13.28M | 10.17M |
| R&D % of Revenue | 1723.1% | 876.31% | - | - | - | - | - | - | - | 52884.52% | - | - | - | - | - | 10631.04% | - | 73165.93% | 15343.75% | 7160057.75% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 1000K | -40 | 0 | 382 | -294 | 237 | 312 | 799 | -421 | -123 | 188 | -404 | -48 | 342 |
| Operating Income | -24.73M | -91.49M | -25.89M | -21.03M | -14.22M | -17.19M | -11.23M | -10.36M | -11.12M | -9.59M | -9.81M | -8.93M | -10.94M | -10.62M | -8.77M | -13.35M | -14.66M | -17.43M | -17.34M | -14.4M |
| Operating Margin % | -2380.08% | -843.71% | - | - | - | - | - | - | - | -95908.34% | - | - | - | - | - | -17804.21% | - | -98870.2% | -20028.82% | -10144001.41% |
| Operating Income Growth % | -73.85% | -432.21% | -130.42% | -103.04% | -27.97% | -79.24% | -14.47% | -15.99% | -1.59% | 9.71% | -11.93% | 33.12% | 25.37% | 39.04% | 49.43% | 7.3% | -2.66% | -11.93% | -26.3% | -2.12% |
| EBITDA | -24.66M | -91.44M | -25.86M | -21.03M | -14.04M | -17.02M | -11.23M | -10.35M | -11.1M | -9.57M | -9.77M | -8.89M | -10.9M | -10.58M | -8.72M | -13.3M | -14.6M | -17.36M | -17.27M | -14.34M |
| EBITDA Margin % | -2373.92% | -843.21% | - | - | - | - | - | - | - | -95675.37% | - | - | - | - | - | -17731.18% | - | -98520.45% | -19950.97% | -10096476.76% |
| EBITDA Growth % | -75.73% | -437.4% | -130.34% | -103.26% | -26.45% | -77.84% | -14.89% | -16.42% | -1.86% | 9.54% | -12.05% | 33.18% | 25.37% | 39.09% | 49.51% | 7.24% | -2.74% | -12.03% | -26.42% | -2.13% |
| D&A (Non-Cash Add-back) | 64K | 54K | 28K | 2K | 0 | 0 | 8.13K | 12.42K | 14.62K | 23.3K | 42.75K | 43.42K | 43.84K | 45.72K | 47.35K | 54.77K | 59.31K | 61.64K | 67.38K | 67.48K |
| EBIT | -23.28M | -90.4M | -24.61M | -20.72M | -14.04M | -17.02M | -5.72M | -10.36M | -11.12M | -9.59M | -9.81M | -8.93M | -10.94M | -10.62M | -8.77M | -13.35M | -14.66M | -17.43M | -17.34M | -14.4M |
| Net Interest Income | 1.45M | 1.09M | 1.28M | -760K | -924K | -676K | 184.52K | 262.29K | 378.36K | 512.19K | 610.98K | 671.03K | 581.67K | 378.26K | 243.6K | 85.59K | 7.07K | 4.08K | 4.63K | 5.22K |
| Interest Income | 1.45M | 1.09M | 1.28M | 313K | 188K | 176K | 184.52K | 262.29K | 378.36K | 512.19K | 610.98K | 671.03K | 581.67K | 378.26K | 243.6K | 85.59K | 7.07K | 4.08K | 4.63K | 5.22K |
| Interest Expense | 0 | 0 | 0 | 1.07M | 1.11M | 852K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 1.45M | 1.09M | 1.28M | -760K | -924K | -676K | 1.41M | 262.25K | 378.36K | 512.58K | 610.68K | 671.27K | 581.98K | 379.06K | 243.18K | 85.47K | 7.26K | 3.67K | 4.58K | 5.56K |
| Pretax Income | -23.28M | -90.4M | -24.61M | -21.79M | -15.15M | -17.87M | -9.82M | -10.1M | -10.74M | -9.08M | -9.2M | -8.26M | -10.36M | -10.24M | -8.52M | -13.27M | -14.65M | -17.42M | -17.33M | -14.4M |
| Pretax Margin % | -2240.9% | -833.61% | - | - | - | - | - | - | - | -90782.58% | - | - | - | - | - | -17690.25% | - | -98849.36% | -20023.53% | -10140083.8% |
| Income Tax | 0 | 2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | -2.21% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -23.28M | -92.4M | -24.61M | -21.79M | -15.15M | -17.87M | -9.82M | -10.1M | -10.74M | -9.08M | -9.2M | -8.26M | -10.36M | -10.24M | -8.52M | -13.27M | -14.65M | -17.42M | -17.33M | -14.4M |
| Net Margin % | -2240.9% | -852.06% | - | - | - | - | - | - | - | -90786.4% | - | - | - | - | - | -17690.09% | - | -98847.07% | -20023.48% | -10140324.65% |
| Net Income Growth % | -53.7% | -417.14% | -150.47% | -115.84% | -41.09% | -96.8% | -6.76% | -22.24% | -3.64% | 11.38% | -7.96% | 37.75% | 29.3% | 41.2% | 50.82% | 7.86% | -2.66% | -11.95% | -26.31% | -2.27% |
| Net Income (Continuing) | -23.28M | -92.4M | -24.61M | -21.79M | -15.15M | -17.87M | -9.82M | -10.1M | -10.74M | -9.08M | -9.2M | -8.26M | -10.36M | -10.24M | -8.52M | -13.27M | -14.65M | -17.42M | -17.33M | -14.4M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.70 | -4.01 | -1.27 | -4.93 | -0.78 | -0.92 | -0.15 | -0.16 | -0.17 | -0.14 | -0.14 | -0.13 | -0.17 | -0.19 | -0.16 | -0.25 | -0.28 | -0.33 | -0.34 | -0.28 |
| EPS Growth % | 10.26% | -335.87% | -746.67% | -2981.25% | -358.82% | -557.14% | -7.14% | -23.08% | 0% | 26.32% | 12.5% | 48% | 39.29% | 42.42% | 52.94% | 10.71% | 0% | -3.13% | -17.24% | 12.5% |
| EPS (Basic) | -0.70 | -4.01 | -1.27 | -4.93 | -0.78 | -0.92 | -0.15 | -0.16 | -0.17 | -0.14 | -0.14 | -0.13 | -0.17 | -0.19 | -0.16 | -0.25 | -0.28 | -0.33 | -0.34 | -0.28 |
| Diluted Shares Outstanding | 30.4M | 20.17M | 16.54M | 3.86M | 19.5M | 19.5M | 64.48M | 64.48M | 64.46M | 64.39M | 64.35M | 64.28M | 60.35M | 52.96M | 52.42M | 52.41M | 52.33M | 52.01M | 51.56M | 51.54M |
| Basic Shares Outstanding | 30.4M | 20.17M | 16.54M | 3.86M | 19.5M | 19.5M | 64.48M | 64.48M | 64.46M | 64.39M | 64.35M | 64.28M | 60.35M | 52.96M | 52.42M | 52.41M | 52.33M | 52.01M | 51.56M | 51.54M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |